CameronFJ, BaghurstPA, RodbardD. Assessing glycaemic variation: why, how and when?Pediatr Endocrinol Rev, 2010; 7,Suppl 3:432–444.
2.
RodbardD. Optimizing display, analysis, interpretation and utility of self-monitoring of blood glucose (SMBG) data for management of patients with diabetes. J Diabetes Sci Technol, 2007; 1:62–71.
3.
RodbardD. Predicting the risk of hypo- and hyperglycemia by time of day, date, and day of the week—new methods for calculation and graphical display [abstract 491-P]Diabetes, 2010; 59,Suppl 1:A132.
4.
KilpatrickES. Arguments for and against the role of glucose variability in the development of diabetes complications. J Diabetes Sci Technol, 2009; 3:649–655.
5.
WeberC, SchnellO. The assessment of glycemic variability and its impact on diabetes-related complications: an overview. Diabetes Technol Ther, 2009; 11:623–633.
6.
HirschIB. Glycemic variability: it's not just about A1C anymore!Diabetes Technol Ther, 2005; 7:780–783.
7.
HirschIB, BrownleeM. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care, 2007; 30:186–187.
8.
BrownleeM, HirschIB. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA, 2006; 295:1707–1708.
9.
SchisanoB, TripathiG, McGeeK, McTernanPG, CerielloA. Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells. Diabetologia, 2011; 54:1219–1226.
10.
SiegelaarSE, HollemanF, HoekstraJB, DevriesJH. Glucose variability; does it matter?Endocr Rev, 2010; 31:171–182.
11.
SiegelaarSE, KilpatrickES, RigbyAS, AtkinSL, HoekstraJB, DevriesJH. Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT. Diabetologia, 2009; 52:2229–2232.
12.
SiegelaarSE, KulikW, van LentheH, MukherjeeR, HoekstraJB, DevriesJH. A randomized clinical trial comparing the effect of basal insulin and inhaled mealtime insulin on glucose variability and oxidative stress. Diabetes Obes Metab, 2009; 11:709–714.
13.
KilpatrickES, RigbyAS, AtkinSL. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care, 2006; 29:1486–1490.
14.
KilpatrickES, RigbyAS, AtkinSL. Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care, 2009; 32:1901–1903.
15.
BragdJ, AdamsonU, BäcklundLB, LinsPE, MobergE, OskarssonP. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?Diabetes Metab, 2008; 34:612–616.
16.
Snell-BergeonJK, RodbardD, RomanR, GargS, MaahsD, SchauerI, BergmanB, KinneyGL, RewersM. Glycaemic variability and coronary artery calcium: the Coronary Artery Calcification in Type 1 Diabetes Study. Diabet Med, 2010; 27:1436–1442.
17.
SiegelaarSE, KerrL, JacoberSJ, DevriesJH. A decrease in glucose variability does not reduce cardiovascular event rates in type 2 diabetic patients after acute myocardial infarction: a reanalysis of the HEART2D study. Diabetes Care, 2011; 34:855–857.
18.
MonnierL, ColetteC. Glycemic variability: can we bridge the divide between controversies?Diabetes Care, 2011; 34:1058–1059.
19.
BorgR, KuenenJC, CarstensenB, ZhengH, NathanDM, HeineRJ, NerupJ, Borch-JohnsenK, WitteDR. ADAG Study Group. HbA1c and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study. Diabetologia, 2011; 54:69–72.
20.
StandlE, SchnellO, CerielloA. Postprandial hyperglycemia and glycemic variability: should we care?Diabetes Care, 2011; 34,Suppl 2:S120–S127.
21.
KovatchevBP, OttoE, CoxD, Gonder-FrederickL, ClarkeW. Evaluation of a new measure of blood glucose variability in diabetes (ADRR)Diabetes Care, 2006; 29:2433–2438.
22.
MazzeRS, LucidoD, LangerO, HartmannK, RodbardD. Ambulatory glucose profile: representation of verified self-monitored blood glucose data. Diabetes Care, 1987; 10:111–117.
23.
MazzeRS, StrockE, WesleyD, BorgmanS, MorganB, BergenstalR, CuddihyR. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol Ther, 2008; 10:149–159.
24.
KovatchevBP, CoxDJ, Gonder-FrederickLA, Young-HymanD, SchlundtD, ClarkeW. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care, 1998; 21:1870–1875.
RodbardD. Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther, 2009; 11,Suppl 1:S55–S57.
27.
RodbardD. New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther, 2009; 11:551–565.
28.
RodbardD. Clinical interpretation of indices of quality of glycemic control and glycemic variability. Postgrad Med, 2011; 123:107–118.
29.
HillNR, HindmarshPC, StevensRJ, StrattonIM, LevyJC, MatthewsDR. A method for assessing quality of control from glucose profiles. Diabet Med, 2007; 24:753–758.
30.
RodbardD, BaileyT, JovanovicL, ZisserH, KaplanR, GargS. Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther, 2009; 11:717–723.
31.
RodbardD, JovanovicL, GargS. Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections. Diabetes Technol Ther, 2009; 11:757–765.
32.
RodbardD. A semilogarithmic scale for glucose provides a balanced view of hyperglycemia and hypoglycemia. J Diabetes Sci Technol, 2009; 3:1395–1401.
ZhouJ, LiH, RanX, YangW, LiQ, PengY, LiY, GaoX, LuanX, WangW, JiaW. Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring. Med Sci Monit, 2011; 17:CR9–CR13.
35.
BaghurstPA. Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm. Diabetes Technol Ther, 2011; 13:296–302.
36.
FritzscheG, KohnertKD, HeinkeP, VogtL, SalzsiederE. The use of a computer program to calculate the mean amplitude of glycemic excursions. Diabetes Technol Ther, 2011; 13:319–325.
WójcickiJM. “J”-index. A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res, 1995; 27:41–42.
39.
MonnierL, WojtusciszynA, ColetteC, OwensD. The contribution of glucose variability to asymptomatic hypoglycemia in persons with type 2 diabetes. Diabetes Technol Ther, 2011; 13:813–818.
40.
QuY, JacoberS, ZhangQ, WolkaL, DeVriesJH. The effect of glucose variability on the rate of hypoglycemic events. Abstract 478-P. Diabetes, 2011; 60,Suppl 1:A133.
HillNR, OliverNS, ChoudharyP, LevyJC, HindmarshP, MatthewsDR. Normal reference range for mean tissue glucose, glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol Ther, 2011; 13:921–928.
43.
MarlingCR, ShubrookJH, VernierSJ, WileyMT, SchwartzFL. Characterizing blood glucose variability using new metrics with continuous glucose monitoring data. J Diabetes Sci Technol, 2011; 5:871–878.
